At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin, a medication proven to fight off parasitic ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Novavax, Inc. (NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following ...

Novavax’s COVID-19 vaccine could soon receive full approval from the United States Food and Drug Administration.

In addition, HHS Secretary Robert F. Kennedy Jr. addressed the delay in Novavax's approval in a CBS interview earlier this ...

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full ...

At the peak of the COVID-19 pandemic, many vaccine skeptics turned to ivermectin ... which is the virus that causes COVID-19. The FDA has not approved ivermectin for use in treating or preventing ...

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a ... speak on behalf of the FDA. Novavax had anticipated ...

Novavax's COVID-19 vaccine could ... Right now, it is only approved under emergency use. That's different from the mRNA vaccines from Pfizer and Moderna, which have full FDA approval for certain ...